Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Upgrades CRH to Buy

Redburn Partners Upgrades CRH to Buy

Redburn Partners analyst Will Jones upgrades CRH (NYSE:CRH) from Neutral to Buy.

byBenzinga Newsdesk

January 3, 2023

1 minute read

Redburn Partners analyst Will Jones upgrades CRH (NYSE:CRH) from Neutral to Buy.

Why Paysafe Stock is Trading Higher Today

By Sean Torres

March 9, 1:49 PM

Paysafe Limited (NYSE: PSFE) shares are trading higher after the company reported better-than-expected fourth-quarter results and reported a 5% year-over-year increase in payment volume.

PSFE

Benchmark Maintains Buy on Staar Surgical, Lowers Price Target to $75

By Benzinga Newsdesk

February 1, 9:18 AM

Benchmark analyst Bruce Jackson maintains Staar Surgical (NASDAQ:STAA) with a Buy and lowers the price target from $78 to $75.

STAA

FDA Rejects Eli Lilly’s Donanemab For Alzheimer’s Disease, Needs More Data

By Vandana Singh

January 20, 6:22 AM

The FDA issued a complete response letter for the accelerated approval submission of Eli Lilly And Co’s (NYSE:LLY) donanemab for early symptomatic…

BIIB

Ambow Education Holding Q2 EPS $(0.23) Down From $0.14 YoY, Sales $16.40M Down From $26.68M YoY

By Benzinga Newsdesk

September 30, 8:07 AM

Ambow Education Holding (AMEX:AMBO) reported quarterly losses of $(0.23) per share. This is a 264.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $16.40 million

AMBO

Redburn Partners Upgrades CRH to Buy

Related Posts

Why Paysafe Stock is Trading Higher Today

Benchmark Maintains Buy on Staar Surgical, Lowers Price Target to $75

FDA Rejects Eli Lilly’s Donanemab For Alzheimer’s Disease, Needs More Data

Ambow Education Holding Q2 EPS $(0.23) Down From $0.14 YoY, Sales $16.40M Down From $26.68M YoY